Select Page

South Delhi Pharma, New Delhi, India

ACTEMRA ® (tocilizumab) injection, for intravenous or subcutaneous use

SDP are here to serve you through the quality pharmaceutical products as per your needs. Established in the year 1996, we have earned a global reputation in the market. Owing to superior quality widest range of Anti Cancer medicines.

ACTEMRA is a prescription medicine. ACTEMRA is used to treat rheumatoid arthritis.
INDICATIONS AND USAGE
ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist indicated for treatment of:
Rheumatoid Arthritis (RA), Polyarticular Juvenile Idiopathic Arthritis (PJIA), idiopathic arthritis.
Systemic Juvenile Idiopathic Arthritis (SJIA).
DOSAGE FORMS & STRENGTHS
Intravenous Infusion Injection: 80 mg/4 mL (20 mg/mL), 200 mg/10 mL (20 mg/mL), 400 mg/20 mL (20 mg/mL) in single-dose vials for further dilution prior to intravenous infusion Subcutaneous Injection
Injection: 162 mg/0.9 mL in a single-dose prefilled syringe or single-dose prefilled ACTPen® autoinjector.
Manufactured By: Genentech
Prescribing Information URL: Click Here

South Delhi Pharma can facilitate the supply of “ACTEMRA ® (tocilizumab) injection” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

8 + 15 =

Tocilizumab (INN, trade name Actemra), also known as atlizumab, is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R).

Reviews

There are no reviews yet.

Be the first to review “ACTEMRA ® (tocilizumab) injection, for intravenous or subcutaneous use”

Your email address will not be published. Required fields are marked *